Acromegaly
189
12
12
125
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
43 trials with published results (23%)
Research Maturity
125 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
8.5%
16 terminated out of 189 trials
88.7%
+2.1% vs benchmark
28%
53 trials in Phase 3/4
34%
43 of 125 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 125 completed trials
Clinical Trials (189)
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)
A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly
A Study to Evaluate MAR002 for Acromegaly
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
Korean Regulatory Post Marketing Surveillance for Somavert
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
Direct Versus Video Laryngoscopy in Patients With Acromegaly
ACRODAT Prospective Evaluation Study
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
Study of MAR002 in Healthy Men
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Reproducibility and Utility of OGTT in Acromegaly
A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Effects of Pasireotide Lar Therapy on Bone Metabolism